Challenges in Alzheimer's Drug Development

Today Alzheimer's Speaks Radio  Host, Lori La Bey is going to talk with Dr Elliot Goldstein, with ProMIS Neurosciences about a highly awaited Phase 3 trial and the challenges in Alzheimer's drug development.

Further Infomration on ProMIS Neurosciences

Website:  www.promisneurosciences.com

Additional Resources:

https://alzheimersnewstoday.com/2018/01/11/study-shows-promis-alzheimers-therapy-attacks-only-harmful-protein-in-brain/

http://www.bioworld.com/report/BWIS03052018PromisNeurosciences.pdf

For Additional Resources from Alzheimer's Speaks